Dura Pharmaceuticals was a San Diego-based specialty pharmaceutical company focused on the development and marketing of prescription drugs, including synthetic peptides for the treatment of allergies and asthma. The company was acquired by Elan Corporation in November 2000 for approximately $1.8 billion in a stock swap transaction.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountNov 2000
Sep 2000
Create a free account to see which investors have funded this company.
Create Free Account
BridgeBio Pharma is a clinical-stage biopharmaceutical company developing therapies for genetic d...
R&D company with 6 SBIR/STTR awards from Department of Health and Human Services.
Biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases
Clinical-stage biotech developing treatments for complex rare diseases, with lead compound target...
Clinical-stage biotech developing innovative sustained-release therapeutics for serious retinal d...
Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying anti...
